Guntaka Saimanoj, Lin Allan, Bae Suhwoo, Vaysblat Michael, Pierce Matthew
Internal Medicine, Northwell Health, Manhasset, USA.
Cardiology, Northwell Health, Manhasset, USA.
Cureus. 2024 Jun 3;16(6):e61615. doi: 10.7759/cureus.61615. eCollection 2024 Jun.
Myxedema coma is a rare and life-threatening consequence of severe hypothyroidism, often precipitated by physiologic stressors. While cardiac manifestations are common, they are typically reversible with prompt treatment. Here, we report a case of a 23-year-old male with untreated hypothyroidism who presented with myxedema coma-induced cardiomyopathy leading to refractory cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and, ultimately, orthotopic heart transplantation (OHT). Our case highlights a rare occurrence of refractory shock necessitating mechanical support as a bridge to a cardiac transplant. We emphasize early recognition, aggressive management, and a low threshold to escalate care to mitigate the high mortality associated with myxedema coma.
黏液性水肿昏迷是严重甲状腺功能减退症罕见且危及生命的后果,通常由生理应激因素诱发。虽然心脏表现很常见,但通过及时治疗通常是可逆的。在此,我们报告一例23岁未治疗的甲状腺功能减退男性患者,其因黏液性水肿昏迷诱发心肌病,导致难治性心源性休克,需要静脉-动脉体外膜肺氧合(VA-ECMO)支持,最终接受原位心脏移植(OHT)。我们的病例突出了难治性休克罕见地需要机械支持作为心脏移植桥梁的情况。我们强调早期识别、积极管理以及提高护理级别阈值,以减轻与黏液性水肿昏迷相关的高死亡率。